✦ LIBER ✦

Gefitinib + celecoxib in head and neck cancer

Book ID: 120852987
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200515100-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-cancer effects of celecoxib in head

Anti-cancer effects of celecoxib in head and neck carcinoma

✍ Young-Youn Kim; Eun-Jin Lee; Yu-Kyoung Kim; Soung-Min Kim; Ju-Yong Park; Hoon My 📂 Article 📅 2010 🏛 Korean Society for Molecular and Cellular Biology 🌐 English ⚖ 452 KB

OP0012 Chemotherapy with gefitinib in re

OP0012 Chemotherapy with gefitinib in recurrent and metastatic head and neck cancer

✍ Gupta, D.; Rao, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 38 KB

8589 POSTER COX-2 Inhibitor and Gefitini

8589 POSTER COX-2 Inhibitor and Gefitinib in Recurrent And/or Metastatic Head & Neck Cancer

✍ Bhattacharwa, G.S.; Malhotra, H.; Babu, K. Govind; Biswas, G.; Ranade, A.A.; Par 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Gefitinib (ZD1839, Iressa™) as palliativ

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

✍ Kirby, A M; A'hern, R P; D'ambrosio, C; Tanay, M; Syrigos, K N; Rogers, S J; Box 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Phase 1 trial of concurrent erlotinib, c

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

✍ Johnny Kao; Eric M. Genden; Chien-Ting Chen; Michael Rivera; Charles C. L. Tong; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

Head and neck cancer

✍ David S. Soutar 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 270 KB